Prime Medicine PRME Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$49.12M+5.3% | -$46.08M-9.0% | -$50.58M+3.7% | -$52.59M+4.9% | -$51.89M-13.4% | ||
| $1.86M+9.2% | $1.88M+9.3% | $1.88M+20.7% | $1.86M+21.2% | $1.7M+29.3% | ||
| $4.64M-18.3% | $4.52M-24.0% | $12.75M+86.7% | $6.33M-21.8% | $5.68M+9.1% | ||
| $0-100% | —— | -$120K-100% | $103K— | $17K— | ||
| $3.55M+88.5% | —— | $3.04M— | -$3.35M+0.1% | $1.88M+132% | ||
| -$4.5M+32.4% | —— | -$1.07M-118% | —— | -$6.66M-48.7% | ||
| -$1.22M-255% | -$2.6M-141% | -$1.3M-119% | -$1.44M— | $789K-71.8% | ||
| -$856K+40.5% | -$751K— | -$1.18M-102% | -$995K— | -$1.44M— | ||
| $0+100% | $539K— | $1.45M— | -$505K+73.8% | -$1.06M-191% | ||
| $2.84M+17.8% | $2.6M+17.9% | $2.33M+4.7% | $2.35M-48.6% | $2.41M-27.9% | ||
| -$1.92M-200% | -$1.71M-276% | -$1.6M-378% | -$1.42M+36.0% | -$638K+81.6% | ||
| -$42.71M+12.6% | -$37.26M— | -$35.04M-35.2% | -$41.41M+9.0% | -$48.86M+27.8% | ||
| $214K-91.2% | $290K-83.8% | $247K-80.7% | $1.57M-17.4% | $2.42M+4.2% | ||
| $7.28M-84.9% | $15.88M— | $134.31M+1,191% | $6.91M-75.9% | $48.32M-54.9% | ||
| $50.89M+1,596% | —— | $42.43M-30.8% | $11.25M-70.0% | $3M-95.9% | ||
| $43.39M+191% | —— | -$92.12M-283% | —— | -$47.74M-28.9% | ||
| $393K— | $0— | $0-100% | $0— | $0-100% | ||
| $393K-93.5% | $562K+56,100% | $144.75M+276% | $197K+463% | $6M-96.2% | ||
| $1.07M+101% | -$8.36M-113% | —— | -$38.44M— | -$90.6M-272% | ||
| $431K+163% | $788K+443% | $574K-34.0% | $411K-70.7% | $164K-75.7% | ||
| -$4.5M+32.4% | —— | -$1.07M-118% | —— | -$6.66M-48.7% | ||
| -$1.92M-200% | -$1.71M-276% | -$1.6M-378% | -$1.42M+36.0% | -$638K+81.6% | ||
| -$1.22M-255% | -$2.6M-141% | -$1.3M-119% | -$1.44M— | $789K-71.8% | ||
| $2.84M+17.8% | $2.6M+17.9% | $2.33M+4.7% | $2.35M-48.6% | $2.41M-27.9% | ||
| —— | $0+100% | $0+100% | $0+100% | $0+100% | ||
| $7.28M-84.9% | $15.88M— | $134.31M+1,191% | $6.91M-75.9% | $48.32M-54.9% | ||
| $50.89M+1,596% | $39.1M+18.8% | $42.43M-30.8% | $11.25M-70.0% | $3M-95.9% | ||
| $0-100% | —— | $6M— | —— | $6M0.0% | ||
| $0-100% | $114K-89.1% | -$148K— | —— | $985K+18.2% | ||
| -$856K+40.5% | -$751K— | -$1.18M-102% | -$995K— | -$1.44M— | ||
| -$1.92M-200% | -$1.71M-276% | -$1.6M-378% | -$1.42M+36.0% | -$638K+81.6% | ||
| $0-100% | —— | —— | —— | $83.76M+86.4% | ||
| $0-100% | —— | —— | —— | $3.12M— | ||
| —— | $2.73M— | $2.73M— | $2.73M— | $2.73M— | ||
| -$42.92M+16.3% | -$37.55M— | -$35.29M-29.8% | -$42.98M+9.3% | -$51.28M+26.8% | ||
| -$42.92M+16.3% | -$37.55M— | -$35.29M-29.8% | -$42.98M+9.3% | -$51.28M+26.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Prime Medicine generate?
- Prime Medicine (PRME) generated -$156.4M in operating cash flow over the trailing twelve months.
- What is Prime Medicine's free cash flow?
- After $2.3M of capital expenditures, Prime Medicine's free cash flow was -$158.7M over the trailing twelve months, up 19.0% year over year.
- Where does Prime Medicine's cash flow data come from?
- Every line is extracted from Prime Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
